Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michaela Sousares"'
Autor:
Zhenze Zhao, Veronica Partridge, Michaela Sousares, Spencer D Shelton, Cory L Holland, Alexander Pertsemlidis, Liqin Du
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208777 (2018)
microRNA-2110 (miR-2110) was previously identified as inducing neurite outgrowth in a neuroblastoma cell lines BE(2)-C, suggesting its differentiation-inducing and oncosuppressive function in neuroblastoma. In this study, we demonstrated that synthet
Externí odkaz:
https://doaj.org/article/f51b1abfd38b4550aa111eb8eade0663
Autor:
Lauren Byrne, Swati Khanna, Rebecca Martin, Caleigh Howard, Lilia Rabia, Michaela Sousares, Jay Zhao, John Majercak, Eric Poma, Chris Moore
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a5d1ae9ea8f4bdf10ea54a1eb1e43af
https://doi.org/10.1136/jitc-2022-sitc2022.0817
https://doi.org/10.1136/jitc-2022-sitc2022.0817
Autor:
Swati Khanna, Elizabeth M. Kapeel, Lauren R. Byrne, Elizabeth Saputra, Steven Rivera, Lindsey Aschenbach, Lilia A. Rabia, Garrett L. Cornelison, Rachael M. Orlandella, Brigitte Brieschke, Michaela Sousares, Jay Zhao, Garrett L. Robinson, Chris Moore, Joseph D. Dekker
Publikováno v:
Cancer Research. 82:3543-3543
Targeting of PD-L1 checkpoint has shown clinical efficacy in multiple solid tumor indications. Currently approved PD-L1 targeted approaches rely on the blocking activity of monoclonal antibodies (mAbs) which sterically inhibit PD-L1 thus preventing P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c2dbc19c675d76e5455c7b7a21f5cb7
https://doi.org/10.1158/1538-7445.am2022-3543
https://doi.org/10.1158/1538-7445.am2022-3543
Autor:
Swati Khanna, Joseph D. Dekker, Betty Chang, Lilia A. Rabia, Garrett L. Robinson, Hilario J. Ramos, Garrett L. Cornelison, Elizabeth Saputra, Wenzhao Dong, Michaela Sousares, Jay Zhao, Lindsey Aschenbach
Publikováno v:
Cancer Research. 81:1628-1628
Targeting PD-L1 has shown clinical efficacy in multiple solid tumor indications. Currently approved PD-L1 targeted approaches rely on monoclonal antibodies which sterically inhibit PD-L1 and prevent PD-1 mediated checkpoint activity. While these mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c7c64bc122dc64e14639891733e046
https://doi.org/10.1158/1538-7445.am2021-1628
https://doi.org/10.1158/1538-7445.am2021-1628
Publikováno v:
Advances in Modern Oncology Research, Vol 3, Iss 5, Pp 213-222 (2017)
Neuroblastoma is one of the most common and aggressive types of pediatric cancers, making up about 7% of all childhood cancers. Neuroblastoma arises from the failure of neural crest cell precursors to differentiate, and inducing cell differentiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6d7e47797ff73be2351c9c9cc31ee2b
https://doi.org/10.18282/amor.v3.i5.233
https://doi.org/10.18282/amor.v3.i5.233
Publikováno v:
Med One, Vol 2, Iss 3 (2017)
Neuroblastoma is a pediatric cancer that arises from neural crest cells failing to differentiate into mature neuronal cells. Differentiation therapy is one of the effective approaches to treat high-risk neuroblastoma. Developing new differentiation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27aea95b71ea12aec36dd64381f4fcfb
https://doi.org/10.20900/mo.20170010
https://doi.org/10.20900/mo.20170010
Autor:
Garrett L. Robinson, Jack P. Higgins, Brigitte Brieschke, Michaela Sousares, Hilario J. Ramos, Jensing Liu, Sara Le Mar, Veronica Partridge, Erin Willert, Joseph D. Dekker, Shaoyou Chu, Pablo A. Maceda, Aimee Iberg, Asis K. Sarkar
Publikováno v:
Cancer Research. 79:3900-3900
Engineered Toxin Bodies (ETBs) are comprised of a deimmunized Shiga-like toxin subunit A (SLTA) genetically fused to an antibody-like targeting domain. The antibody targeting domain allows for specific targeting of cancer cells while the SLTA compone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f024970a13557d5364526260a0dc752
https://doi.org/10.1158/1538-7445.am2019-3900
https://doi.org/10.1158/1538-7445.am2019-3900
Autor:
Spencer D. Shelton, Zhenze Zhao, Veronica Partridge, Cory L. Holland, Liqin Du, Alexander Pertsemlidis, Michaela Sousares
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208777 (2018)
PLoS ONE
PLoS ONE
microRNA-2110 (miR-2110) was previously identified as inducing neurite outgrowth in a neuroblastoma cell lines BE(2)-C, suggesting its differentiation-inducing and oncosuppressive function in neuroblastoma. In this study, we demonstrated that synthet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e27fb364185a28e2f9f39b8a37fbc64
https://doi.org/10.1371/journal.pone.0208777
https://doi.org/10.1371/journal.pone.0208777